Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
ad [2023/07/03 12:25] – [Alzheimer's Disease and Mild Cognitive Impairment] sflitmanad [2024/03/10 21:43] (current) – [Alzheimer's Disease and Mild Cognitive Impairment] sflitman
Line 5: Line 5:
 ^ Condition(s) ^ Type of Drug ^ Phase ^ Add-On ^ Placebo ^ Duration ^ Open Label Extension ^ ^ Condition(s) ^ Type of Drug ^ Phase ^ Add-On ^ Placebo ^ Duration ^ Open Label Extension ^
 | MCI and Mild AD |  Anti-Tau Oligonucleotide Spinal Injection  |  II  |  Yes  |  33%  |  54 weeks  |  Anticipated  |  | MCI and Mild AD |  Anti-Tau Oligonucleotide Spinal Injection  |  II  |  Yes  |  33%  |  54 weeks  |  Anticipated  | 
-| MCI and Mild AD |  Oral Filamin A Stabilizer  |  III  |  Yes  |  50%  | 1 year  |  52 weeks  | +| Agitation in Mild to Moderate AD |  Similar to Nuedexta  |  III  |  Yes  |  50%  |  12 weeks  |  No  | 
-| Mild to Moderate AD |  Oral Amyloid Receptor Blocker  |  II  |  Yes  |  33%  |  8 months  |  No  | +
  
 Also see [[imaging|Imaging]]. Also see [[imaging|Imaging]].

Trace:

Print/export
QR Code
QR Code ad (generated for current page)